Risikofaktorer for blødende magesår
Open Access
- 1 January 2010
- journal article
- research article
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 130 (11), 1135-1139
- https://doi.org/10.4045/tidsskr.08.0693
Abstract
Many drugs increase the risk for gastroduodenal ulcer bleeding. The aim of this study was to investigate Helicobacter pylori infection and drug use in patients who had gastroduodenal ulcer bleeding in 2002 or 2007, and possible differences between the periods. Patients with gastroduodenal ulcer bleeding were prospectively included in the periods 1.1 - 31.12. 2002 and 1.1 - 31.12. 2007. Information was recorded about Helicobacter pylori infection and intake of NSAIDs (non steroidal anti-inflammatory drugs), acetylsalicylic acid, warfarin, clopidogrel, low-molecular heparine, SSRIs (selective serotonin reuptake inhibitors), corticosteroids, paracetamol and proton pump inhibitors. Inhabitants in Oslo age >or= 60 years in 2007, were used as a control for drug use. 78.2 % of patients in 2002 and 90.7 % of those in 2007 used at least one of the drugs (p = 0.01). In 2002, 25.7 % of patients used non-selective NSAIDs and in 2007 46.1 % used such drugs (p = 0.001). In 2002, 36.7 % of patients used more than one of the studied drugs, versus 50.9 % in 2007 (p = 0.02). Compared to controls, the patients used more NSAIDs, acetylsalicylic acid, clopidogrel, low- molecular heparine, SSRIs and corticosteroids. Helicobacter pylori infection was diagnosed in 51.0 % of patients in 2002, versus 41.1 % in 2007 (p = 0.11). Most patients with gastroduodenal ulcer bleeding use drugs that have a known risk of adverse effects such as ulcer and/or gastrointestinal bleeding.Keywords
This publication has 27 references indexed in Scilit:
- Helicobacter pylori infection in peptic ulcer haemorrhageAlimentary Pharmacology & Therapeutics, 2002
- Preventing gastrointestinal complications of NSAIDsPostgraduate Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysisBMJ, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Association Between Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Tract Bleeding/PerforationArchives of Internal Medicine, 2000
- Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.JAMA, 1999
- A guideline for the treatment and prevention of NSAID-induced ulcersAmerican Journal Of Gastroenterology, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United KingdomBMJ, 1995